JCAP vs JNJ · rev $613.3M vs P/E 17, rev $49.37B
Jefferson Capital, Inc (JCAP) versus Johnson & Johnson (JNJ) — a side-by-side from cached financials, not a winner call.
Jefferson Capital, Inc (JCAP) is a credit services company listed on US.
Johnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
Latest reported JCAP revenue for 2025-12-31 was $613.3M. Net income was $188.0M. Revenue was up 41.5% from 2024-12-31 to 2025-12-31. JCAP currently screens at market cap $0.
Latest reported JNJ revenue for 2026-06-28 was $49.37B. Net income was $10.77B. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
JCAP currently screens at market cap $0. JNJ currently screens at market cap $375.37B and trailing P/E 17.4.
Not investment advice. Open the JCAP and JNJ stock pages for the full models.
Not investment advice.